BIOMAT Database Logo BIOMAT Database Logo

[Analysis of immunocompetent cell subpopulations in chronic bronchitis patients during the use of different immunomodulating preparations]. 1984

A V Karaulov, and V P Sil'vestrov, and V Iu Martsinovskiĭ, and N A Bulycheva, and V F Likov

Twenty-seven patients with chronic obstructive bronchitis and 47 patients with chronic non-obstructive bronchitis were subjected to subpopulation analysis of peripheral blood immunocompetent cells. Statistically significant changes in the content of T mu and T gamma cells, killer and suppressor activity of lymphocytes were discovered in patients with chronic bronchitis. One of the immunological differences between chronic obstructive and chronic non-obstructive bronchitis lies in the activity of Con A-induced suppressors, which is appreciably lowered in patients with chronic obstructive bronchitis.

UI MeSH Term Description Entries
D007665 Ketotifen A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis. 4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)-cyclohepta(1,2-b)thiophen-10-one,Ketotifen Fumarate,Ketotifene,Ketotiphen,Ketotiphene,Zaditen,Fumarate, Ketotifen
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D007978 Levamisole An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6) L-Tetramisole,Levotetramisole,Decaris,Dekaris,Levamisole Hydrochloride,Solaskil,Hydrochloride, Levamisole
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011354 Prodigiozan A polysaccharide extracted from Serratia marcescens and other bacteria. It activates enzymatic activity of macrophages and stimulates phagocytic processes. Prodigiosan
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003208 Concanavalin A A MANNOSE/GLUCOSE binding lectin isolated from the jack bean (Canavalia ensiformis). It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A V Karaulov, and V P Sil'vestrov, and V Iu Martsinovskiĭ, and N A Bulycheva, and V F Likov
[Use of chlotazol as an immunomodulating agent in chronic bronchitis].
April 1991, Klinicheskaia meditsina,
A V Karaulov, and V P Sil'vestrov, and V Iu Martsinovskiĭ, and N A Bulycheva, and V F Likov
[Comparative study of the effectiveness of immunomodulating preparations in combined therapy of chronic obstructive bronchitis].
January 1995, Klinicheskaia meditsina,
A V Karaulov, and V P Sil'vestrov, and V Iu Martsinovskiĭ, and N A Bulycheva, and V F Likov
[Chronic bronchitis and immunomodulating therapy].
January 1987, Giornale italiano di chemioterapia,
A V Karaulov, and V P Sil'vestrov, and V Iu Martsinovskiĭ, and N A Bulycheva, and V F Likov
[The use and side effects of antibacterial preparations in chronic bronchitis].
January 1991, Terapevticheskii arkhiv,
A V Karaulov, and V P Sil'vestrov, and V Iu Martsinovskiĭ, and N A Bulycheva, and V F Likov
[Use of immunomodulating preparations in the complex treatment of children with different forms of rheumatism].
May 1984, Pediatriia,
A V Karaulov, and V P Sil'vestrov, and V Iu Martsinovskiĭ, and N A Bulycheva, and V F Likov
[The efficacy of immunomodulating preparations in treating patients with chronic cholestatic liver diseases].
January 1992, Likars'ka sprava,
A V Karaulov, and V P Sil'vestrov, and V Iu Martsinovskiĭ, and N A Bulycheva, and V F Likov
[The use of colloidal gold for the immunocytochemical analysis of subpopulations of immunocompetent cells].
January 1993, Klinicheskaia laboratornaia diagnostika,
A V Karaulov, and V P Sil'vestrov, and V Iu Martsinovskiĭ, and N A Bulycheva, and V F Likov
[The immunomodulating action of vilozen and splenin in angina patients against a background of chronic bronchitis].
August 1992, Likars'ka sprava,
A V Karaulov, and V P Sil'vestrov, and V Iu Martsinovskiĭ, and N A Bulycheva, and V F Likov
[Immunomodulating therapy with indomethacin and levamisole in patients with chronic bronchitis and bronchial asthma].
June 1985, Klinicheskaia meditsina,
A V Karaulov, and V P Sil'vestrov, and V Iu Martsinovskiĭ, and N A Bulycheva, and V F Likov
[Pathogenetic substantiation of the use of immunomodulating preparations in the treatment of chronic viral hepatitis B in children].
May 1986, Pediatriia,
Copied contents to your clipboard!